Lyrica Package Insert

The package insert (FDA approved label) for Lyrica (pregabalin) contains dosage, contraindications, adverse reactions, approved indications and usage, and other pertinent information. Lyrica is not approved for the treatment of nerve pain or epilepsy in children. Lyrica is used to treat various conditions such as partial onset seizures, postherpetic neuralgia, diabetic peripheral neuropathy, and muscle pain associated with fibromyalgia.